On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Pharmalex GmbH's own share of each project, not the project's full budget.
- Horizon 2020€676k · 1 project
- Horizon Europe€602k · 1 project
Projects
2 EU-funded projects, newest first. Each links to the official record.
- INSPIREPartner
Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delivered by tailored aerosol delivery technology for the treatment of lung cancer
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€602ktheir share - iPSpinePartner
Induced pluripotent stem cell-based therapy for spinal regeneration
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€676ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Universiteit UtrechtNetherlands · 1 shared project
- Technische Universiteit EindhovenNetherlands · 1 shared project
- The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinIreland · 1 shared project
- Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
- Eberhard Karls Universitaet TuebingenGermany · 1 shared project
- The University of SheffieldUnited Kingdom · 1 shared project
- Academisch Ziekenhuis LeidenNetherlands · 1 shared project
- University of GalwayIreland · 1 shared project
- Universitaet BernSwitzerland · 1 shared project
- Deutsches Krebsforschungszentrum HeidelbergGermany · 1 shared project
- Universitaet UlmGermany · 1 shared project
- Universite de MontpellierFrance · 1 shared project
- Nantes UniversiteFrance · 1 shared project
- Sheffield Hallam UniversityUnited Kingdom · 1 shared project
- Universita Campus Bio Medico di RomaItaly · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- RNA
- biomaterials
- cell biology
- gene therapy
- immunotherapy
- lung cancer
- pharmaceutical drugs
- physiotherapy
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.